Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$12.19 - $28.17 $3.66 Million - $8.45 Million
-300,107 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$29.47 - $35.0 $206 - $245
7 Added 0.0%
300,107 $9.62 Million
Q3 2020

Nov 12, 2020

BUY
$26.17 - $43.07 $785 - $1,292
30 Added 0.01%
300,100 $9.07 Million
Q1 2020

May 13, 2020

BUY
$18.18 - $39.48 $5.46 Million - $11.8 Million
300,070 New
300,070 $7.49 Million

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $89.4M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.